LNA Santé S.A.

LNA.PA

Medical - Care Facilities · Healthcare

Also trades as: 0OR2.L

Exchange

Euronext Paris

Winston Score

Winston is serious

Mixed quality — meaningful strengths and weaknesses.

Data as of Aug 23, 2026 · filings through Dec 31, 2025

How the score breaks down

Quality

Weak

Growth

Good

Cash Flow

Strong

Stability

Mixed

Valuation

Good

Track this stock — start free trial

Winston Score History

The full picture

LNA Santé is a French healthcare company that runs nursing homes and care facilities for elderly people. It also operates clinics that help patients recover after surgery or serious illness. The main customers are elderly residents needing long-term care and patients referred by hospitals for rehabilitation. LNA Santé is one of the mid-sized private care operators in France.

The company makes money by charging daily fees for beds in its facilities, with payments coming from residents, their families, and the French public health insurance system. LNA Santé operates almost entirely in France, with a small number of facilities in Portugal. With roughly 25,000 beds across its network, its competitive position depends on its regional density and relationships with local health authorities. The key growth driver is France's aging population, which is expected to increase demand for elder care over the coming decades, though the business faces ongoing pressure from rising staff costs and tight government reimbursement rates.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+11.8% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+50.6% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

46.0%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

€112M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

LNA Santé S.A. is a rare growth stock that's already generating positive cash flow while growing at 12%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

14.8%

Thin — 14.8% gross margin

Profit after running costs

Operating Margin

7.1%

Modest — 7.1% operating margin

Return on the money invested

ROCE

7.4%

Weak — 7.4% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+13.1%

Fast-growing sales (+13.1% YoY)

Profit growth

EPS YoY

+15.2%

Earnings growing fast (+15.2% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

292%

Turns 292% of profit into real cash

Spare cash per sale

FCF Margin

6.5%

Modest free cash flow (6.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

1.46

Elevated debt (1.46)

Covers its interest

Interest Cover

2.02x

Tight — interest eats into profit (2.0x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

14.3x

no trend

Attractive valuation — P/E 14.3

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial